Fungal peritonitis at a tertiary care community teaching hospital: epidemiology, treatments, and outcome over a 3 year timespan

Mycoses. 2004 Jun;47(5-6):200-2. doi: 10.1111/j.1439-0507.2004.00978.x.

Abstract

Fungal species isolated from the peritoneal cavity over a 3-year period were equally divided among dialysis and intra-abdominal sources and demonstrated that triazole antifungal susceptible species predominated. The evolution toward triazole-resistant species/strains noted in bloodstream infections has not yet developed in fungal peritonitis. A trend toward non-albicans species in continuous ambulatory peritoneal dialysis (CAPD) cases, however, requires careful monitoring. .

MeSH terms

  • Antifungal Agents / therapeutic use*
  • Candidiasis / drug therapy*
  • Candidiasis / epidemiology*
  • Hospitals, Teaching
  • Humans
  • Peritoneal Dialysis, Continuous Ambulatory
  • Peritonitis / drug therapy*
  • Peritonitis / epidemiology*
  • Peritonitis / mortality
  • Prognosis
  • Treatment Outcome
  • Triazoles / therapeutic use

Substances

  • Antifungal Agents
  • Triazoles